nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—prostate gland—urinary bladder cancer	0.0469	0.111	CbGeAlD
Miglustat—UGCG—prostate gland—urinary bladder cancer	0.0462	0.109	CbGeAlD
Miglustat—GBA2—seminal vesicle—urinary bladder cancer	0.0396	0.0935	CbGeAlD
Miglustat—UGCG—seminal vesicle—urinary bladder cancer	0.0391	0.0922	CbGeAlD
Miglustat—GBA2—renal system—urinary bladder cancer	0.0319	0.0753	CbGeAlD
Miglustat—UGCG—renal system—urinary bladder cancer	0.0315	0.0743	CbGeAlD
Miglustat—GBA2—urethra—urinary bladder cancer	0.0314	0.074	CbGeAlD
Miglustat—UGCG—urethra—urinary bladder cancer	0.0309	0.073	CbGeAlD
Miglustat—GBA2—female reproductive system—urinary bladder cancer	0.0256	0.0603	CbGeAlD
Miglustat—UGCG—female reproductive system—urinary bladder cancer	0.0252	0.0595	CbGeAlD
Miglustat—GBA2—vagina—urinary bladder cancer	0.0231	0.0546	CbGeAlD
Miglustat—UGCG—vagina—urinary bladder cancer	0.0228	0.0538	CbGeAlD
Miglustat—GBA2—lymph node—urinary bladder cancer	0.015	0.0353	CbGeAlD
Miglustat—UGCG—lymph node—urinary bladder cancer	0.0147	0.0348	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—TERT—urinary bladder cancer	0.011	0.1	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—IL2—urinary bladder cancer	0.00653	0.0593	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—urinary bladder cancer	0.00511	0.0464	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00467	0.0424	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00427	0.0388	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTZ1—urinary bladder cancer	0.00266	0.0242	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTO2—urinary bladder cancer	0.00253	0.023	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NAT1—urinary bladder cancer	0.00253	0.023	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00248	0.0226	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTZ1—urinary bladder cancer	0.00244	0.0221	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NAT1—urinary bladder cancer	0.00231	0.021	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTO2—urinary bladder cancer	0.00231	0.021	CbGpPWpGaD
Miglustat—GBA2—Metabolism—UGT2B7—urinary bladder cancer	0.00231	0.021	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00227	0.0206	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UGT2B7—urinary bladder cancer	0.00211	0.0192	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP4B1—urinary bladder cancer	0.00208	0.0189	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC19A1—urinary bladder cancer	0.00196	0.0179	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PRSS3—urinary bladder cancer	0.00191	0.0174	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP4B1—urinary bladder cancer	0.0019	0.0173	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC19A1—urinary bladder cancer	0.0018	0.0163	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PRSS3—urinary bladder cancer	0.00175	0.0159	CbGpPWpGaD
Miglustat—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00162	0.00347	CcSEcCtD
Miglustat—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00161	0.00345	CcSEcCtD
Miglustat—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00161	0.00345	CcSEcCtD
Miglustat—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.0016	0.00344	CcSEcCtD
Miglustat—Gait disturbance—Epirubicin—urinary bladder cancer	0.0016	0.00343	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00153	0.0139	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TYMP—urinary bladder cancer	0.00153	0.0139	CbGpPWpGaD
Miglustat—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00153	0.00328	CcSEcCtD
Miglustat—Influenza like illness—Epirubicin—urinary bladder cancer	0.00152	0.00325	CcSEcCtD
Miglustat—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.0015	0.00322	CcSEcCtD
Miglustat—Gait disturbance—Doxorubicin—urinary bladder cancer	0.00148	0.00317	CcSEcCtD
Miglustat—Visual impairment—Cisplatin—urinary bladder cancer	0.00147	0.00316	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00147	0.0134	CbGpPWpGaD
Miglustat—Chills—Gemcitabine—urinary bladder cancer	0.00147	0.00315	CcSEcCtD
Miglustat—Convulsion—Thiotepa—urinary bladder cancer	0.00147	0.00315	CcSEcCtD
Miglustat—Neuropathy—Epirubicin—urinary bladder cancer	0.00147	0.00314	CcSEcCtD
Miglustat—Cramps of lower extremities—Epirubicin—urinary bladder cancer	0.00143	0.00308	CcSEcCtD
Miglustat—Eye disorder—Cisplatin—urinary bladder cancer	0.00143	0.00306	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.0014	0.0128	CbGpPWpGaD
Miglustat—Influenza like illness—Doxorubicin—urinary bladder cancer	0.0014	0.00301	CcSEcCtD
Miglustat—UGCG—Metabolism—TYMP—urinary bladder cancer	0.0014	0.0127	CbGpPWpGaD
Miglustat—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00139	0.00299	CcSEcCtD
Miglustat—GBA2—Metabolism—NAT2—urinary bladder cancer	0.00138	0.0126	CbGpPWpGaD
Miglustat—Back pain—Gemcitabine—urinary bladder cancer	0.00138	0.00296	CcSEcCtD
Miglustat—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00136	0.00291	CcSEcCtD
Miglustat—Neuropathy—Doxorubicin—urinary bladder cancer	0.00136	0.00291	CcSEcCtD
Miglustat—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00135	0.00291	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00134	0.0122	CbGpPWpGaD
Miglustat—Malnutrition—Cisplatin—urinary bladder cancer	0.00133	0.00285	CcSEcCtD
Miglustat—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	0.00133	0.00285	CcSEcCtD
Miglustat—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00132	0.00284	CcSEcCtD
Miglustat—Anorexia—Thiotepa—urinary bladder cancer	0.00132	0.00283	CcSEcCtD
Miglustat—Flatulence—Cisplatin—urinary bladder cancer	0.00131	0.00281	CcSEcCtD
Miglustat—Eye disorder—Etoposide—urinary bladder cancer	0.00131	0.0028	CcSEcCtD
Miglustat—Malaise—Gemcitabine—urinary bladder cancer	0.00129	0.00276	CcSEcCtD
Miglustat—Visual disturbance—Methotrexate—urinary bladder cancer	0.00128	0.00274	CcSEcCtD
Miglustat—Muscle spasms—Cisplatin—urinary bladder cancer	0.00128	0.00274	CcSEcCtD
Miglustat—UGCG—Metabolism—NAT2—urinary bladder cancer	0.00127	0.0115	CbGpPWpGaD
Miglustat—Chills—Etoposide—urinary bladder cancer	0.00125	0.00269	CcSEcCtD
Miglustat—Tremor—Cisplatin—urinary bladder cancer	0.00124	0.00267	CcSEcCtD
Miglustat—Paraesthesia—Thiotepa—urinary bladder cancer	0.00124	0.00266	CcSEcCtD
Miglustat—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00123	0.00265	CcSEcCtD
Miglustat—Dyspepsia—Thiotepa—urinary bladder cancer	0.00122	0.00261	CcSEcCtD
Miglustat—Convulsion—Fluorouracil—urinary bladder cancer	0.00121	0.00261	CcSEcCtD
Miglustat—Decreased appetite—Thiotepa—urinary bladder cancer	0.0012	0.00258	CcSEcCtD
Miglustat—Discomfort—Gemcitabine—urinary bladder cancer	0.0012	0.00257	CcSEcCtD
Miglustat—Malaise—Cisplatin—urinary bladder cancer	0.0012	0.00257	CcSEcCtD
Miglustat—GBA2—Metabolism—RRM2—urinary bladder cancer	0.00119	0.0109	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00119	0.00256	CcSEcCtD
Miglustat—Fatigue—Thiotepa—urinary bladder cancer	0.00119	0.00256	CcSEcCtD
Miglustat—Constipation—Thiotepa—urinary bladder cancer	0.00118	0.00254	CcSEcCtD
Miglustat—Pain—Thiotepa—urinary bladder cancer	0.00118	0.00254	CcSEcCtD
Miglustat—Discomfort—Fluorouracil—urinary bladder cancer	0.00118	0.00253	CcSEcCtD
Miglustat—Back pain—Etoposide—urinary bladder cancer	0.00118	0.00253	CcSEcCtD
Miglustat—Muscle spasms—Etoposide—urinary bladder cancer	0.00117	0.00251	CcSEcCtD
Miglustat—Convulsion—Cisplatin—urinary bladder cancer	0.00115	0.00247	CcSEcCtD
Miglustat—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00114	0.00245	CcSEcCtD
Miglustat—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00114	0.00245	CcSEcCtD
Miglustat—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00114	0.00244	CcSEcCtD
Miglustat—Ataxia—Methotrexate—urinary bladder cancer	0.00114	0.00244	CcSEcCtD
Miglustat—Pain in extremity—Epirubicin—urinary bladder cancer	0.00113	0.00243	CcSEcCtD
Miglustat—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00113	0.00243	CcSEcCtD
Miglustat—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00113	0.00242	CcSEcCtD
Miglustat—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00112	0.00241	CcSEcCtD
Miglustat—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00112	0.0024	CcSEcCtD
Miglustat—Discomfort—Cisplatin—urinary bladder cancer	0.00112	0.0024	CcSEcCtD
Miglustat—Migraine—Epirubicin—urinary bladder cancer	0.00112	0.00239	CcSEcCtD
Miglustat—Anorexia—Gemcitabine—urinary bladder cancer	0.00111	0.00238	CcSEcCtD
Miglustat—GBA2—Metabolism—HPGDS—urinary bladder cancer	0.00111	0.0101	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ENO2—urinary bladder cancer	0.00111	0.0101	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.0011	0.01	CbGpPWpGaD
Miglustat—Malaise—Etoposide—urinary bladder cancer	0.0011	0.00236	CcSEcCtD
Miglustat—Vertigo—Etoposide—urinary bladder cancer	0.00109	0.00235	CcSEcCtD
Miglustat—Abdominal pain—Thiotepa—urinary bladder cancer	0.00109	0.00235	CcSEcCtD
Miglustat—UGCG—Metabolism—RRM2—urinary bladder cancer	0.00109	0.00993	CbGpPWpGaD
Miglustat—Anorexia—Fluorouracil—urinary bladder cancer	0.00109	0.00234	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTT1—urinary bladder cancer	0.00107	0.00975	CbGpPWpGaD
Miglustat—Ataxia—Epirubicin—urinary bladder cancer	0.00107	0.00229	CcSEcCtD
Miglustat—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00106	0.00228	CcSEcCtD
Miglustat—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00106	0.00228	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00106	0.0096	CbGpPWpGaD
Miglustat—Convulsion—Etoposide—urinary bladder cancer	0.00105	0.00226	CcSEcCtD
Miglustat—Insomnia—Gemcitabine—urinary bladder cancer	0.00105	0.00226	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00105	0.00225	CcSEcCtD
Miglustat—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00104	0.00224	CcSEcCtD
Miglustat—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00103	0.00222	CcSEcCtD
Miglustat—Insomnia—Fluorouracil—urinary bladder cancer	0.00103	0.00222	CcSEcCtD
Miglustat—Anorexia—Cisplatin—urinary bladder cancer	0.00103	0.00222	CcSEcCtD
Miglustat—Migraine—Doxorubicin—urinary bladder cancer	0.00103	0.00221	CcSEcCtD
Miglustat—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00103	0.0022	CcSEcCtD
Miglustat—Discomfort—Etoposide—urinary bladder cancer	0.00102	0.0022	CcSEcCtD
Miglustat—UGCG—Metabolism—ENO2—urinary bladder cancer	0.00101	0.0092	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HPGDS—urinary bladder cancer	0.00101	0.0092	CbGpPWpGaD
Miglustat—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00101	0.00217	CcSEcCtD
Miglustat—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00101	0.00216	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00101	0.00914	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.001	0.00215	CcSEcCtD
Miglustat—Fatigue—Gemcitabine—urinary bladder cancer	0.001	0.00215	CcSEcCtD
Miglustat—Muscular weakness—Epirubicin—urinary bladder cancer	0.000999	0.00214	CcSEcCtD
Miglustat—Constipation—Gemcitabine—urinary bladder cancer	0.000995	0.00213	CcSEcCtD
Miglustat—Pain—Gemcitabine—urinary bladder cancer	0.000995	0.00213	CcSEcCtD
Miglustat—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000994	0.00213	CcSEcCtD
Miglustat—Asthenia—Thiotepa—urinary bladder cancer	0.000992	0.00213	CcSEcCtD
Miglustat—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000988	0.00212	CcSEcCtD
Miglustat—Abdominal distension—Epirubicin—urinary bladder cancer	0.000986	0.00212	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—urinary bladder cancer	0.000986	0.00211	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTT1—urinary bladder cancer	0.000981	0.00892	CbGpPWpGaD
Miglustat—Pain—Fluorouracil—urinary bladder cancer	0.000978	0.0021	CcSEcCtD
Miglustat—Paraesthesia—Cisplatin—urinary bladder cancer	0.000974	0.00209	CcSEcCtD
Miglustat—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000973	0.00209	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000966	0.00878	CbGpPWpGaD
Miglustat—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000959	0.00206	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000958	0.00205	CcSEcCtD
Miglustat—Anorexia—Etoposide—urinary bladder cancer	0.000947	0.00203	CcSEcCtD
Miglustat—Diarrhoea—Thiotepa—urinary bladder cancer	0.000946	0.00203	CcSEcCtD
Miglustat—Decreased appetite—Cisplatin—urinary bladder cancer	0.000943	0.00202	CcSEcCtD
Miglustat—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000943	0.00202	CcSEcCtD
Miglustat—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000936	0.00201	CcSEcCtD
Miglustat—Depression—Methotrexate—urinary bladder cancer	0.00093	0.002	CcSEcCtD
Miglustat—Pain—Cisplatin—urinary bladder cancer	0.000927	0.00199	CcSEcCtD
Miglustat—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000925	0.00198	CcSEcCtD
Miglustat—Dizziness—Thiotepa—urinary bladder cancer	0.000915	0.00196	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000912	0.00196	CcSEcCtD
Miglustat—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000894	0.00192	CcSEcCtD
Miglustat—Paraesthesia—Etoposide—urinary bladder cancer	0.000892	0.00191	CcSEcCtD
Miglustat—GBA2—Metabolism—NQO1—urinary bladder cancer	0.000892	0.0081	CbGpPWpGaD
Miglustat—Weight decreased—Epirubicin—urinary bladder cancer	0.000886	0.0019	CcSEcCtD
Miglustat—Vomiting—Thiotepa—urinary bladder cancer	0.000879	0.00189	CcSEcCtD
Miglustat—Headache—Thiotepa—urinary bladder cancer	0.000866	0.00186	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000865	0.00786	CbGpPWpGaD
Miglustat—Decreased appetite—Etoposide—urinary bladder cancer	0.000864	0.00185	CcSEcCtD
Miglustat—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000858	0.00184	CcSEcCtD
Miglustat—Fatigue—Etoposide—urinary bladder cancer	0.000857	0.00184	CcSEcCtD
Miglustat—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000856	0.00184	CcSEcCtD
Miglustat—Constipation—Etoposide—urinary bladder cancer	0.00085	0.00182	CcSEcCtD
Miglustat—Pain—Etoposide—urinary bladder cancer	0.00085	0.00182	CcSEcCtD
Miglustat—Haemoglobin—Methotrexate—urinary bladder cancer	0.000842	0.00181	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—urinary bladder cancer	0.000838	0.0018	CcSEcCtD
Miglustat—Asthenia—Gemcitabine—urinary bladder cancer	0.000835	0.00179	CcSEcCtD
Miglustat—Nausea—Thiotepa—urinary bladder cancer	0.000822	0.00176	CcSEcCtD
Miglustat—Weight decreased—Doxorubicin—urinary bladder cancer	0.00082	0.00176	CcSEcCtD
Miglustat—Feeling abnormal—Etoposide—urinary bladder cancer	0.000819	0.00176	CcSEcCtD
Miglustat—UGCG—Metabolism—NQO1—urinary bladder cancer	0.000816	0.00741	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000812	0.00174	CcSEcCtD
Miglustat—Visual impairment—Methotrexate—urinary bladder cancer	0.000807	0.00173	CcSEcCtD
Miglustat—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000796	0.00171	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000792	0.0017	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000791	0.00719	CbGpPWpGaD
Miglustat—Haemoglobin—Epirubicin—urinary bladder cancer	0.000788	0.00169	CcSEcCtD
Miglustat—Abdominal pain—Etoposide—urinary bladder cancer	0.000785	0.00168	CcSEcCtD
Miglustat—Haemorrhage—Epirubicin—urinary bladder cancer	0.000784	0.00168	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—urinary bladder cancer	0.000783	0.00168	CcSEcCtD
Miglustat—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000783	0.00168	CcSEcCtD
Miglustat—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00078	0.00167	CcSEcCtD
Miglustat—Asthenia—Cisplatin—urinary bladder cancer	0.000778	0.00167	CcSEcCtD
Miglustat—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00077	0.00165	CcSEcCtD
Miglustat—Dizziness—Fluorouracil—urinary bladder cancer	0.000756	0.00162	CcSEcCtD
Miglustat—Visual impairment—Epirubicin—urinary bladder cancer	0.000755	0.00162	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000754	0.00686	CbGpPWpGaD
Miglustat—Chills—Methotrexate—urinary bladder cancer	0.000752	0.00161	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTP1—urinary bladder cancer	0.000744	0.00676	CbGpPWpGaD
Miglustat—Diarrhoea—Cisplatin—urinary bladder cancer	0.000742	0.00159	CcSEcCtD
Miglustat—Vomiting—Gemcitabine—urinary bladder cancer	0.00074	0.00159	CcSEcCtD
Miglustat—Mental disorder—Methotrexate—urinary bladder cancer	0.000734	0.00157	CcSEcCtD
Miglustat—Eye disorder—Epirubicin—urinary bladder cancer	0.000733	0.00157	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—urinary bladder cancer	0.000729	0.00156	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000729	0.00156	CcSEcCtD
Miglustat—Headache—Gemcitabine—urinary bladder cancer	0.000729	0.00156	CcSEcCtD
Miglustat—Vomiting—Fluorouracil—urinary bladder cancer	0.000727	0.00156	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000725	0.00156	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000722	0.00155	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.00072	0.00654	CbGpPWpGaD
Miglustat—Headache—Fluorouracil—urinary bladder cancer	0.000717	0.00154	CcSEcCtD
Miglustat—Asthenia—Etoposide—urinary bladder cancer	0.000713	0.00153	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000713	0.00153	CcSEcCtD
Miglustat—Back pain—Methotrexate—urinary bladder cancer	0.000705	0.00151	CcSEcCtD
Miglustat—Chills—Epirubicin—urinary bladder cancer	0.000703	0.00151	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—urinary bladder cancer	0.000699	0.0015	CcSEcCtD
Miglustat—GBA2—Metabolism—TYMS—urinary bladder cancer	0.000691	0.00628	CbGpPWpGaD
Miglustat—Nausea—Gemcitabine—urinary bladder cancer	0.000691	0.00148	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00069	0.00627	CbGpPWpGaD
Miglustat—Vomiting—Cisplatin—urinary bladder cancer	0.00069	0.00148	CcSEcCtD
Miglustat—Mental disorder—Epirubicin—urinary bladder cancer	0.000687	0.00147	CcSEcCtD
Miglustat—GBA2—Metabolism—NCOR1—urinary bladder cancer	0.000683	0.00621	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTM1—urinary bladder cancer	0.000683	0.00621	CbGpPWpGaD
Miglustat—Malnutrition—Epirubicin—urinary bladder cancer	0.000682	0.00146	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTP1—urinary bladder cancer	0.00068	0.00618	CbGpPWpGaD
Miglustat—Diarrhoea—Etoposide—urinary bladder cancer	0.00068	0.00146	CcSEcCtD
Miglustat—Nausea—Fluorouracil—urinary bladder cancer	0.000679	0.00146	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—urinary bladder cancer	0.000678	0.00145	CcSEcCtD
Miglustat—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000677	0.00145	CcSEcCtD
Miglustat—Flatulence—Epirubicin—urinary bladder cancer	0.000672	0.00144	CcSEcCtD
Miglustat—Nervousness—Epirubicin—urinary bladder cancer	0.000663	0.00142	CcSEcCtD
Miglustat—Back pain—Epirubicin—urinary bladder cancer	0.00066	0.00142	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000658	0.00598	CbGpPWpGaD
Miglustat—Malaise—Methotrexate—urinary bladder cancer	0.000658	0.00141	CcSEcCtD
Miglustat—Dizziness—Etoposide—urinary bladder cancer	0.000657	0.00141	CcSEcCtD
Miglustat—Muscle spasms—Epirubicin—urinary bladder cancer	0.000656	0.00141	CcSEcCtD
Miglustat—Vertigo—Methotrexate—urinary bladder cancer	0.000655	0.00141	CcSEcCtD
Miglustat—GBA2—Metabolism—GPX1—urinary bladder cancer	0.000654	0.00595	CbGpPWpGaD
Miglustat—Chills—Doxorubicin—urinary bladder cancer	0.000651	0.0014	CcSEcCtD
Miglustat—Nausea—Cisplatin—urinary bladder cancer	0.000644	0.00138	CcSEcCtD
Miglustat—GBA2—Metabolism—ERCC2—urinary bladder cancer	0.000643	0.00584	CbGpPWpGaD
Miglustat—Mental disorder—Doxorubicin—urinary bladder cancer	0.000635	0.00136	CcSEcCtD
Miglustat—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000633	0.00136	CcSEcCtD
Miglustat—UGCG—Metabolism—TYMS—urinary bladder cancer	0.000632	0.00575	CbGpPWpGaD
Miglustat—Convulsion—Methotrexate—urinary bladder cancer	0.000632	0.00136	CcSEcCtD
Miglustat—Vomiting—Etoposide—urinary bladder cancer	0.000632	0.00136	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—urinary bladder cancer	0.000631	0.00135	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTM1—urinary bladder cancer	0.000625	0.00568	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NCOR1—urinary bladder cancer	0.000625	0.00568	CbGpPWpGaD
Miglustat—Headache—Etoposide—urinary bladder cancer	0.000622	0.00134	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—urinary bladder cancer	0.000622	0.00133	CcSEcCtD
Miglustat—Malaise—Epirubicin—urinary bladder cancer	0.000615	0.00132	CcSEcCtD
Miglustat—Discomfort—Methotrexate—urinary bladder cancer	0.000613	0.00132	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—urinary bladder cancer	0.000613	0.00132	CcSEcCtD
Miglustat—Vertigo—Epirubicin—urinary bladder cancer	0.000613	0.00132	CcSEcCtD
Miglustat—Back pain—Doxorubicin—urinary bladder cancer	0.000611	0.00131	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000607	0.0013	CcSEcCtD
Miglustat—GBA2—Metabolism—MTHFR—urinary bladder cancer	0.000604	0.00549	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GPX1—urinary bladder cancer	0.000599	0.00544	CbGpPWpGaD
Miglustat—Convulsion—Epirubicin—urinary bladder cancer	0.000591	0.00127	CcSEcCtD
Miglustat—Nausea—Etoposide—urinary bladder cancer	0.00059	0.00127	CcSEcCtD
Miglustat—UGCG—Metabolism—ERCC2—urinary bladder cancer	0.000588	0.00534	CbGpPWpGaD
Miglustat—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000586	0.00126	CcSEcCtD
Miglustat—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000584	0.00125	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000583	0.00125	CcSEcCtD
Miglustat—Discomfort—Epirubicin—urinary bladder cancer	0.000574	0.00123	CcSEcCtD
Miglustat—Malaise—Doxorubicin—urinary bladder cancer	0.000569	0.00122	CcSEcCtD
Miglustat—Dry mouth—Epirubicin—urinary bladder cancer	0.000568	0.00122	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—urinary bladder cancer	0.000567	0.00122	CcSEcCtD
Miglustat—Anorexia—Methotrexate—urinary bladder cancer	0.000567	0.00122	CcSEcCtD
Miglustat—UGCG—Metabolism—MTHFR—urinary bladder cancer	0.000552	0.00502	CbGpPWpGaD
Miglustat—Convulsion—Doxorubicin—urinary bladder cancer	0.000547	0.00117	CcSEcCtD
Miglustat—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000546	0.00117	CcSEcCtD
Miglustat—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000545	0.00117	CcSEcCtD
Miglustat—Insomnia—Methotrexate—urinary bladder cancer	0.000538	0.00115	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—urinary bladder cancer	0.000534	0.00115	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—urinary bladder cancer	0.000531	0.00114	CcSEcCtD
Miglustat—Anorexia—Epirubicin—urinary bladder cancer	0.000531	0.00114	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—urinary bladder cancer	0.000526	0.00113	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—urinary bladder cancer	0.000524	0.00112	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—urinary bladder cancer	0.000517	0.00111	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000514	0.0011	CcSEcCtD
Miglustat—Fatigue—Methotrexate—urinary bladder cancer	0.000513	0.0011	CcSEcCtD
Miglustat—Pain—Methotrexate—urinary bladder cancer	0.000509	0.00109	CcSEcCtD
Miglustat—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000505	0.00108	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000505	0.00108	CcSEcCtD
Miglustat—Insomnia—Epirubicin—urinary bladder cancer	0.000504	0.00108	CcSEcCtD
Miglustat—Paraesthesia—Epirubicin—urinary bladder cancer	0.0005	0.00107	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—urinary bladder cancer	0.000491	0.00105	CcSEcCtD
Miglustat—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00049	0.00105	CcSEcCtD
Miglustat—Dyspepsia—Epirubicin—urinary bladder cancer	0.00049	0.00105	CcSEcCtD
Miglustat—GBA2—Metabolism—PPARG—urinary bladder cancer	0.00049	0.00445	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000487	0.00104	CcSEcCtD
Miglustat—Decreased appetite—Epirubicin—urinary bladder cancer	0.000484	0.00104	CcSEcCtD
Miglustat—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000481	0.00103	CcSEcCtD
Miglustat—Fatigue—Epirubicin—urinary bladder cancer	0.00048	0.00103	CcSEcCtD
Miglustat—Pain—Epirubicin—urinary bladder cancer	0.000476	0.00102	CcSEcCtD
Miglustat—Constipation—Epirubicin—urinary bladder cancer	0.000476	0.00102	CcSEcCtD
Miglustat—GBA2—Metabolism—CREBBP—urinary bladder cancer	0.000471	0.00428	CbGpPWpGaD
Miglustat—Abdominal pain—Methotrexate—urinary bladder cancer	0.00047	0.00101	CcSEcCtD
Miglustat—Insomnia—Doxorubicin—urinary bladder cancer	0.000466	0.001	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000463	0.000993	CcSEcCtD
Miglustat—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000459	0.000985	CcSEcCtD
Miglustat—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000455	0.000977	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000454	0.000973	CcSEcCtD
Miglustat—UGCG—Metabolism—PPARG—urinary bladder cancer	0.000448	0.00407	CbGpPWpGaD
Miglustat—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000448	0.000961	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000445	0.000954	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—urinary bladder cancer	0.000444	0.000953	CcSEcCtD
Miglustat—Pain—Doxorubicin—urinary bladder cancer	0.000441	0.000945	CcSEcCtD
Miglustat—Constipation—Doxorubicin—urinary bladder cancer	0.000441	0.000945	CcSEcCtD
Miglustat—Abdominal pain—Epirubicin—urinary bladder cancer	0.00044	0.000944	CcSEcCtD
Miglustat—UGCG—Metabolism—CREBBP—urinary bladder cancer	0.00043	0.00391	CbGpPWpGaD
Miglustat—Asthenia—Methotrexate—urinary bladder cancer	0.000427	0.000916	CcSEcCtD
Miglustat—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000425	0.000911	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000421	0.000904	CcSEcCtD
Miglustat—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000407	0.000874	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—urinary bladder cancer	0.000407	0.000874	CcSEcCtD
Miglustat—Asthenia—Epirubicin—urinary bladder cancer	0.0004	0.000857	CcSEcCtD
Miglustat—Dizziness—Methotrexate—urinary bladder cancer	0.000394	0.000844	CcSEcCtD
Miglustat—GBA2—Metabolism—PTGS2—urinary bladder cancer	0.000385	0.0035	CbGpPWpGaD
Miglustat—Diarrhoea—Epirubicin—urinary bladder cancer	0.000381	0.000817	CcSEcCtD
Miglustat—Vomiting—Methotrexate—urinary bladder cancer	0.000378	0.000812	CcSEcCtD
Miglustat—Headache—Methotrexate—urinary bladder cancer	0.000373	0.0008	CcSEcCtD
Miglustat—Asthenia—Doxorubicin—urinary bladder cancer	0.00037	0.000793	CcSEcCtD
Miglustat—Dizziness—Epirubicin—urinary bladder cancer	0.000368	0.00079	CcSEcCtD
Miglustat—Vomiting—Epirubicin—urinary bladder cancer	0.000354	0.00076	CcSEcCtD
Miglustat—Nausea—Methotrexate—urinary bladder cancer	0.000353	0.000758	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000353	0.000756	CcSEcCtD
Miglustat—UGCG—Metabolism—PTGS2—urinary bladder cancer	0.000352	0.0032	CbGpPWpGaD
Miglustat—Headache—Epirubicin—urinary bladder cancer	0.000349	0.000748	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—urinary bladder cancer	0.000341	0.000731	CcSEcCtD
Miglustat—GBA2—Metabolism—PTEN—urinary bladder cancer	0.000336	0.00305	CbGpPWpGaD
Miglustat—Nausea—Epirubicin—urinary bladder cancer	0.000331	0.00071	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—urinary bladder cancer	0.000328	0.000703	CcSEcCtD
Miglustat—Headache—Doxorubicin—urinary bladder cancer	0.000323	0.000693	CcSEcCtD
Miglustat—GBA2—Metabolism—EP300—urinary bladder cancer	0.00032	0.00291	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—urinary bladder cancer	0.000307	0.00279	CbGpPWpGaD
Miglustat—Nausea—Doxorubicin—urinary bladder cancer	0.000306	0.000657	CcSEcCtD
Miglustat—UGCG—Metabolism—EP300—urinary bladder cancer	0.000293	0.00266	CbGpPWpGaD
